EXACT Therapeutics AS (OSL:EXTX)
Norway
· Delayed Price · Currency is NOK 1.480
+0.050 (3.50%)
At close: Apr 28, 2026
EXACT Therapeutics AS Revenue
In the year 2025, EXACT Therapeutics AS had annual revenue of 59.00K NOK. EXACT Therapeutics AS had revenue of 59.00K in the half year ending December 31, 2025.
Revenue
59.00K
Revenue Growth
n/a
P/S Ratio
1,586.94
Revenue / Employee
5.36K
Employees
11
Market Cap
93.63M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aqua Bio Technology ASA | 101.51M |
| Arctic Bioscience AS | 45.90M |
| Oncoinvent ASA | 28.07M |
| SoftOx Solutions AS | 15.58M |
| Zelluna ASA | 53.00K |
| Lytix Biopharma ASA | 377.00K |
| ArcticZymes Technologies ASA | 118.21M |
| Nykode Therapeutics AS | 4.57M |
EXACT Therapeutics AS News
- 2 months ago - EXACT Therapeutics AS Transcript: Investor update - Transcripts
- 1 year ago - EXACT Therapeutics AS Transcript: Status update - Transcripts